20 May 2013
Keywords: enzon, applies, prothecan, usa, applied, approval, begin
Article | 06 April 1999
Enzon has applied for approval to begin clinical trials in the USA ofProthecan (pegylated camptothecin) as a cancer chemotherapeutic.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 March 1999
20 April 1999
17 May 2013
© 2013 thepharmaletter.com